Cargando...
Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
BACKGROUND: Rituximab has been used in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) since 2003. Our objective was to describe outcomes and adverse events following rituximab since that time in an inception cohort. METHODS: Patients with AAV (diagnosed 1991–2012) who receive...
Guardado en:
| Publicado en: | Nephrol Dial Transplant |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4447867/ https://ncbi.nlm.nih.gov/pubmed/25805743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv076 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|